Accreditation Information

In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

CME

This live activity is designated for a maximum of 13 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

CPE

This knowledge-based activity will award 13 contact hours (1.300 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

CDE

This live course meets regulatory requirements for 13 hours credit as permitted by 201 KAR 8:532 for dentists and 201 KAR 8:562 for dental hygienists.

ASWB ACE

As a Jointly Accredited Organization, UK HealthCare CECentral is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. UK HealthCare CECentral maintains responsibility for this course. Social workers completing this course receive 7.25 clinical continuing education credits & 5.75 general continuing education credits.

CNE

The maximum number of hours awarded for this Continuing Nursing Education activity is 13 nursing contact hours. Will offer 4 Pharmacology hours.

Needs Statement

Kentucky is among the states leading the country in HCV infections. It is critical for professionals to have current knowledge to provide effective treatment and education for patients. According to the CDC, Kentucky is at high risk for a HIV outbreak if introduced into the drug using population. HIV therapy was previously limited due to lack of treatment options, but more therapy options increase choice for patient treatment and challenges for providers. Screening for drug misuse is critical to the prevention of or early intervention in addiction.

Objectives

Upon completion of this activity, participants will be able to:
1. Explain appropriate HCV treatment regimens based on subtype, drug interactions & patient characteristics
2. Discuss linking patients with Hepatitis C to proper care
3. Review management of Hepatitis C
4. Outline the importance of Hepatitis C treatment, follow-up and reinfection. Identify key elements for HIV treatment in a rural outbreak
5. Discuss emerging data on newer ART agents in special populations.
6. Explain screening for opioid use disorder.

Target Audience

Attendance of the conference is open to physicians, physician assistants, advanced practice nurses, nurses, pharmacists, dentists, social workers, health educators and therapists who currently provide or could provide care services to persons living with HIV/AIDS or Hepatitis C.

Faculty Disclosure

All planners, speakers, authors, and reviewers involved with content development for continuing education activities provided by the University of Kentucky are expected to disclose any real or perceived conflict of interest related to the content of the activity. Detailed disclosures will be included in participant materials or given prior to the start of the activity.